Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is Swartz Schedule 13G Due According To Rule 13d-1(c) NLT Feb 14?
Actually... I'm not so worried about Swartzy & M/A....  I'm more concerned about how many shares he still has control over and how much longer we will have to endure his selling...
Share
New Message
Please login to post a reply